Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults: A Randomized Controlled Trial

NCT07892742 is registered in ClinicalTrials.gov with Polytechnic University of Santarém as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07892742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Increased Water Intake on Muscle Function, Physical Performance, and Endocrine Regulation in Low-Drinking Older Adults: A Randomized Controlled Trial
Lead sponsor
Polytechnic University of Santarém
Phase
Not applicable
Overall status
Recruiting
Start date
January 1, 2027
Completion date
July 31, 2028
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dehydrated, water-electrolyte imbalance, malnutrition, dehydration (physiology)

Arms

As registered; 2 arms.

  • Increased Water Intake ExperimentalWater

    Participants will maintain their habitual total water intake and usual dietary and physical activity patterns throughout the 7-day study period. Participants will not receive the hydration tools or behavioral support provided to the experimental group.

  • No intervention No intervention

    Participants will maintain their habitual total water intake and usual dietary and physical activity patterns throughout the 7-day study period. No additional water, hydration tools, or behavioral support will be provided. Participants will complete daily food and fluid records to document their habitual intake during the intervention period.

Primary endpoints

Registered primary outcome measures; 7 primary.

  • Absolute and Relative Ankle Plantar-Flexion Peak Force Day 1 (baseline) and Day 7 (post-intervention)

    Absolute peak force (N) and relative peak force (N·kg-¹) during a seated maximal voluntary isometric plantar-flexion contraction of the dominant limb. The highest force value recorded across four trials will be used for analysis.

  • Rate of Force Development During Isometric Ankle Plantar-Flexion Day 1 (baseline) and Day 7 (post-intervention)

    Rate of force development (RFD; N·s-¹) during maximal voluntary isometric plantar-flexion of the dominant limb, calculated over consecutive 50-ms intervals from contraction onset: 0-50, 50-100, 100-150, and 150-200 ms.

  • Rate of Force Development During Dynamic Ankle Plantar-Flexion Day 1 (baseline) and Day 7 (post-intervention)

    Rate of force development (N·s-¹) during a standing bilateral rapid calf-raise task, calculated as peak force (N) divided by time to peak force (s).

  • Explosive Isometric Ankle Plantar-Flexion Force Day 1 (baseline) and Day 7 (post-intervention)

    Explosive force, expressed as the percentage of peak force (%F) attained at 50, 100, 150, and 200 ms following contraction onset during maximal voluntary isometric plantar-flexion of the dominant limb.

  • Peak Force during the 5 repetition STS Day 1 (baseline) and Day 7 (post-intervention)

    Peak vertical ground reaction force (N) recorded during the concentric phase of each sit-to-stand repetition. The participant-level summary measure will be defined a priori.

+2 more primary endpoints

Lead sponsor's other trials

Polytechnic University of Santarém, most recent start first.

Similar trials

Same condition (Dehydration) and phase, most recent start first.